Physician profile
Michael Lanni
NPI 1396276077
$6,763.20
in general payments reported to CMS, 2019-2025
19 companies · $87.36 in 2025
The $87.36 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $220 · 2021: $625 · 2022: $2,591 · 2023: $1,165 · 2024: $1,711 · 2025: $87.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668 · Education: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.12 |
| Education | $294.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,037.24 | 2020-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Medical Device Business Services, INC. | $957.99 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant |
| Abbvie INC. | $944.27 | 2023-2024 | |
| Sientra, INC. | $754.52 | 2022 | |
| Mentor Worldwide LLC | $323.35 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $318.32 | 2022-2024 | Phasix Mesh |
| Tela Bio, INC. | $312.09 | 2022 | |
| Acera Surgical, INC. | $278.72 | 2019-2024 | Restrata Wound Matrix |
| Acumed LLC | $266.54 | 2021 | |
| Depuy Synthes Sales INC. | $248.30 | 2021-2023 | Matrixmandible |
| Axogen | $245.50 | 2022-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Kci USA, INC. | $215.22 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $209.47 | 2024 | |
| Ethicon US, LLC | $164.98 | 2019-2022 | |
| Stryker Corporation | $160.13 | 2024 | 1788 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $144.91 | 2022 | |
| Baxter Healthcare | $109.03 | 2023 | |
| Medtronic, INC. | $53.96 | 2025 | Biosyn |
| Solventum Corporation | $18.66 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.